Recent Progress In Medicinal Plants, Volume 4: Biotechnology And Genetics Engineering
Description:
This volume deals with one of the most important areas of biotechnology research vis-à-vis medicinal plants. Exploitation of medicinal plant wealth demands rational utilization without destroying biodiversity and implementation of measures of conserve the natural resources. Biotechnological techniques offer uncommon opportunities to improve quality and quantity of pharmaceutical compounds in plants and novel methods to extract active principles, which are described in detail. The volume also contains articles on the techniques of micro propagation and in vitro conservation of medicinal plants, efficient procedures for the production of secondary metabolites, expression of recombinant antibodies and edible vaccines and production of anticancer drugs. Other interesting articles include reviews on application of biotechnology tools in the traditional forms of medicine such as Ayurveda and Unani.
Best prices to buy, sell, or rent ISBN 9780965603898
Frequently Asked Questions about Recent Progress In Medicinal Plants, Volume 4: Biotechnology And Genetics Engineering
You can buy the Recent Progress In Medicinal Plants, Volume 4: Biotechnology And Genetics Engineering book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $69.06 on Amazon and is available from 5 sellers at the moment.
If you’re interested in selling back the Recent Progress In Medicinal Plants, Volume 4: Biotechnology And Genetics Engineering book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Recent Progress In Medicinal Plants, Volume 4: Biotechnology And Genetics Engineering book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.